-The Telegraph Meghalaya chief minister today called for a legislation that would protect students from the Northeast from “insensitive behaviour”, almost a week after his niece, Dana Sangma, killed herself in a Delhi hostel after being allegedly ill-treated by an invigilator. Speaking to reporters at the Delhi Press Club today, Sangma asserted that Dana was targeted only because of her background. The 21-year-old, writing her second semester MBA examination at Amity Business School...

This month a group of Dalit (or Untouchables, as they were formerly labelled) students organised a Beef Festival in Osmania University of Hyderabad. It was the festival to assert their culinary rights in public and make a political statement of dietary habits of Dalits and Muslims – by cooking and eating beef Biryani on campus. About 2000 students participated and although it started out well, the festival was disrupted and students...

Rural secondary school students in the Northeast have better reading and arithmetic skills than the rest of the nation, an education survey has revealed, though the numerical knowledge in some states of the region is below the national average. The survey was conducted by volunteers of the Annual Status of Education Report under a Delhi-based NGO, Pratham, for the Union human resource development ministry. Among the Northeast states, Arunachal Pradesh, Mizoram, Nagaland,...

-The Hindu The Rajya Sabha on Thursday passed a crucial Bill that extends the time limit from three to six years for providing reservation to the Scheduled Castes, the Scheduled Tribes and the Other Backward Classes in the Central education institutions. The Bill also seeks to add a proviso that if there are Central educational institutions in a tribal area, the State seats in those institutions shall have reservation for the SCs,...

-The Telegraph An Indian pharmaceutical company has tweaked and tested a synthetic molecule first created in an American university and developed the world's latest drug against malaria, an alternative to standard anti-malarial therapy. India’s Ranbaxy Laboratories today launched the new drug for the treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite, after nine years of research which was partly supported by the Indian government. Clinical trials in India, Tanzania, and Thailand...